Keyphrases
Head-and-neck Cancer
100%
Human Papillomavirus Vaccine
100%
Clinical Trials
100%
Therapeutic Vaccine
100%
Tumor Response
75%
HPV+
75%
Complete Response
50%
Partial Response
50%
Embase
25%
Cochrane
25%
Vaccine Types
25%
Antibody Level
25%
SAFE Strategy
25%
Adverse Events
25%
Cancer Data
25%
Immune Response
25%
Vaccine Safety
25%
Extracted Data
25%
Overall Response Rate
25%
PubMed
25%
Clinical Outcomes
25%
Progression-free Survival
25%
Distant Metastasis
25%
Immunogenicity
25%
Overall Survival
25%
Safety Profile
25%
Patient-initiated
25%
Stable Disease
25%
T Cell Response
25%
Locoregional
25%
Event Outcomes
25%
Pharmacology, Toxicology and Pharmaceutical Science
Therapeutic Vaccine
100%
Wart Virus Vaccine
100%
Clinical Trial
100%
Head and Neck Cancer
100%
Neoplasm
75%
Progression Free Survival
25%
Diseases
25%
Adverse Event
25%
Immunogenicity
25%
Overall Survival
25%
Vaccine
25%
Metastasis
25%